This is a preview of subscription content, log in via an institution to check access.
References and Further Reading
Allison, K. H. (2012). Molecular pathology of breast cancer: What a pathologist needs to know. American Journal of Clinical Pathology, 138, 770–780.
Blamey, R. W., Ellis, I. O., Pinder, S. E., Lee, A. H., Macmillan, R. D., Morgan, D. A., Robertson, J. F., Mitchell, M. J., Ball, G. R., Haybittle, J. L., & Elston, C. W. (2007). Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999. European Journal of Cancer, 43, 1548–1555.
Blamey, R. W., Hornmark-Stenstam, B., Ball, G., Blichert-Toft, M., Cataliotti, L., Fourquet, A., Gee, J., Holli, K., Jakesz, R., Kerin, M., Mansel, R., Nicholson, R., Pienkowski, T., Pinder, S., Sundquist, M., van de Vijver, M., & Ellis, I. (2010). ONCOPOOL – A European database for 16,944 cases of breast cancer. European Journal of Cancer, 46, 56–71.
Carlson, R. W., Brown, E., Burstein, H. J., Gradishar, W. J., Hudis, C. A., Loprinzi, C., Mamounas, E. P., Perez, E. A., Pritchard, K., Ravdin, P., Recht, A., Somlo, G., Theriault, R. L., Winer, E. P., & Wolff, A. C. (2006). NCCN Task Force report: Adjuvant therapy for breast cancer. Journal of the National Comprehensive Cancer Network, 4(Suppl 1), S1–S26.
Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H.-J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S. Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J., Denkert, C., Di Leo, A., Ejlertsen, B., Francis, B., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., Hayes, D. F., Huang, C. S., Huober, J., Khaled, H., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K. C., Pagani, O., Partridge, A. H., Pritchard, K., Ro, J., Rutgers, E. J. T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Tutt, A., Viale, G., Watanabe, T., Whelan, T. J., & Xu, B. (2017). De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Annals of Oncology, 28, 1700–1712.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). (2018). Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: Meta-analysis of individual patient data from ten randomised trials. Lancet Oncology, 19, 27–39.
Ellis, I. O., Al-Sam, S., Anderson, N., Carder, P., Deb, R., Girling, A., Hales, S., Hanby, A., Ibrahim, M., Lee, A. S. H., Liebmann, R., Mallon, E., Pinder, S. E., Provenzano, E., Quinn, C., Rakha, E., Rowlands, D., Stephenson, T., & Wells, C. A. (2016). Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. The Royal College of Pathologists, London. file:https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html#
Elston, C. W., & Ellis, I. O. (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology, 19, 403–410.
Lakhani, S. R., Ellis, I. O., Schnitt, S. J., Tan, P. H., & van de Vijver, M. J. (2012). WHO classification of tumours of the breast (4th ed.). Lyon: IARC Press.
Lee, A. H. (2007). The histological diagnosis of metastases to the breast from extramammary malignancies. Journal of Clinical Pathology, 60, 1333–1341.
Perry, N., Broeders, M., de Wolf, C., Törnberg, S., Holland, R., & von Karsa, L. (2006). European guidelines for quality assurance in breast cancer screening and diagnosis (4th ed.). Luxembourg: Office for Official Publications of the European Communities.
Rakha, E. A., & Green, A. R. (2017). Molecular classification of breast cancer: What the pathologist needs to know. Pathology, 49, 111–119.
Rakha, E. A., Reis-Filho, J. S., Baehner, F., Dabbs, D. J., Decker, T., Eusebi, V., Fox, S. B., Ichihara, S., Jacquemier, J., Lakhani, S. R., Palacios, J., Richardson, A. L., Schnitt, S. J., Schmitt, F. C., Tan, P. H., Tse, G. M., Badve, S., & Ellis, I. O. (2010). Breast cancer prognostic classification in the molecular era: The role of histological grade. Breast Cancer Research, 12, 207.
Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F. L., Penault-Llorca, F., Perez, E. A., Thompson, E. A., Symmans, W. F., Richardson, A. L., Brock, J., Criscitiello, C., Bailey, H., Ignatiadis, M., Floris, G., Sparano, J., Kos, Z., Nielsen, T., Rimm, D. L., Allison, K. H., Reis-Filho, J. S., Loibl, S., Sotiriou, C., Viale, G., Badve, S., Adams, S., Willard-Gallo, K., Loi, S., & International TILs Working Group 2014. (2015). The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: Recommendations by an International TILs Working Group 2014. Annals of Oncology, 26, 259–271.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Ellis, I. (2019). Invasive Carcinoma NST. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_4702-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28845-1_4702-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28845-1
Online ISBN: 978-3-319-28845-1
eBook Packages: Springer Reference MedicineReference Module Medicine